Crossmark

PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells

Crossref DOI link: https://doi.org/10.1136/jitc-2021-002500

Published Online: 2022-01-25

Published Print: 2022-01

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Bajor, Malgorzata

Graczyk-Jarzynka, Agnieszka

Marhelava, Katsiaryna

Burdzinska, Anna

Muchowicz, Angelika

Goral, Agnieszka

Zhylko, Andriy

Soroczynska, Karolina

Retecki, Kuba

Krawczyk, Marta

Klopotowska, Marta

Pilch, Zofia

Paczek, Leszek

Malmberg, Karl-Johan

Wälchli, Sébastien

Winiarska, Magdalena https://orcid.org/0000-0001-5605-3329
Zagozdzon, Radoslaw https://orcid.org/0000-0002-7957-2372
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03330834 at ClinicalTrials.gov

Documents that mention this clinical trial

PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
https://doi.org/10.1136/jitc-2021-002500

Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors
https://doi.org/10.1136/jitc-2021-003050
Funding

Funding for this research was provided by:

Narodowe Centrum Nauki (2015/19/B/NZ6/02862)

Narodowe Centrum Nauki (2016/23/B/NZ6/02535)

Narodowe Centrum Nauki (2019/33/B/NZ6/02503)

H2020 European Research Council (805038/STIMUNO/ERC-2018-STG)

Ministry of Science and Higher Education (013/RID/2018/19)

Ministry of Science and Higher Education (2019–2022)
License Information

License valid from 2022-01-24